Skip to main content
. 2013 Jul 26;1(6):1009–1012. doi: 10.3892/mco.2013.161

Table II.

OS, LRC and DMFS rates during the 3-year follow-up.

Factors 1-year (%) 2-year (%) 3-year (%)
OS 67.9 41.0 33.3
LRC 76.9 55.1 47.4
DMFS 67.9 38.5 30.8

OS, overall survival; LRC, locoregional control; DMFS, distant metastasis-free survival.